Want to see IN:IOLCP full AI Analyst Report?
IOLCP Stock Chart & Stats
₹84.09
-₹4.90(-1.13%)
At close: 4:00 PM EST
₹84.09
-₹4.90(-1.13%)
Day’s Range― - ―
52-Week Range₹67.14 - ₹179.65
Previous CloseN/A
Volume410.76K
Average Volume (3M)113.78K
Market Cap
₹48.17B
Enterprise Value₹29.95K
Total Cash (Recent Filing)₹2.02B
Total Debt (Recent Filing)₹1.35B
Price to Earnings (P/E)35.0
Beta1.64
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.97%
Share Statistics
EPS (TTM)4.69
Shares Outstanding293,527,500
10 Day Avg. Volume248,884
30 Day Avg. Volume113,785
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)1.19
Price to Sales (P/S)0.92
P/FCF Ratio55.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.7
Revenue Forecast (FY)₹26.48B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageVery low leverage (debt/equity ~0.08) and a materially larger equity base give durable financial flexibility. This capital structure supports capital spending, working capital needs, and buffers vs cyclical shocks without immediate reliance on external financing, reinforcing stability over months.
Diversified Manufacturing SegmentsOperating both APIs and specialty/industrial chemicals provides diversified end markets and demand drivers. This reduces single-market dependency, smooths utilization across plants, and allows the firm to reallocate resources or adjust product mix to sustain revenues and production efficiency over multiple months.
Top-line Recovery In Latest YearA return to positive revenue growth (~+6.9% in FY2026) signals recovering demand or improved pricing/mix. Sustained top-line gains support higher plant utilization, better fixed-cost absorption, and provide a foundation for margin and cash-flow improvement if the recovery persists across the next few quarters.
Bears Say
Material Margin CompressionGross and net margins have declined substantially from prior peaks, reducing fundamental earnings power. Lower margins mean less cash generated per revenue dollar, constrain capacity to invest or absorb cost shocks, and make medium-term profitability more sensitive to input costs or pricing pressure.
Inconsistent Free Cash Flow / Weak Cash ConversionVolatile and often weak cash conversion constrains the company's ability to self-fund capex, pay dividends, or build liquidity. Repeated years of negative FCF mean investment or growth may require external financing, reducing resilience to sustained industry or demand shocks over the medium term.
Declining Return On Equity / Reduced Capital EfficiencyROE falling from ~35% to under 8% indicates a step-change in capital efficiency and underlying profitability. Absent structural margin, pricing, or growth improvements, lower ROE signals limited ability to deliver attractive returns to shareholders and may reflect persistent headwinds to earnings generation.
IOL Chemicals & Pharmaceuticals Ltd. News
IOLCP FAQ
What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
IOL Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹67.14 and its highest was ₹179.65 in the past 12 months.
What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?
IOL Chemicals & Pharmaceuticals Ltd.’s market cap is ₹48.17B.
When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 20 days.
How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
IOL Chemicals & Pharmaceuticals Ltd. released its earnings results on May 20, 2026. The company reported ₹1.8 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts IOL Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?
IOL Chemicals & Pharmaceuticals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.97%. See more information on IOL Chemicals & Pharmaceuticals Ltd. dividends here
What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?
IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding.
What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
IOL Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹1.8 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.466%.
Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:IOLCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IOL Chemicals & Pharmaceuticals Ltd.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Technical Analysis
Aarti Drugs Limited
―
Granules India Limited
―
Hikal Limited
―
Neuland Laboratories Ltd.
―
Solara Active Pharma Sciences Ltd.
―